PMID- 27799316 OWN - NLM STAT- MEDLINE DCOM- 20170724 LR - 20180125 IS - 1468-201X (Electronic) IS - 1355-6037 (Linking) VI - 103 IP - 9 DP - 2017 May TI - Longitudinal strain combined with delayed-enhancement magnetic resonance improves risk stratification in patients with dilated cardiomyopathy. PG - 679-686 LID - 10.1136/heartjnl-2016-309746 [doi] AB - OBJECTIVE: Late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) imaging has been reported to be associated with unfavourable outcomes; however, few studies have addressed the prognostic value of left ventricular (LV) deformation parameter indicated by global longitudinal strain (GLS) in two-dimensional speckle-tracking (2DST) echocardiography in patients with non-ischaemic dilated cardiomyopathy (DCM). This study aims to investigate whether the combination of GLS and LGE is useful in stratifying the risk in patients with DCM. METHODS: We studied 179 consecutive symptomatic patients with DCM (age, 61+/-15 years; 121 males; left ventricular ejection fraction (LVEF) 33%+/-9%; New York Heart Association (NYHA) class II: n=71, III: n=107, IV: n=1) who underwent CMR and echocardiography with conventional assessment and 2DST analysis. RESULTS: There were 40 rehospitalisations for heart failure, including 7 cardiac deaths and 2 implantations of LV assist device during follow-up (3.8+/-2.5 years). Univariable Cox proportional hazard regression analysis showed that NYHA class, blood pressure, B-type natriuretic peptide, LV end-diastolic and end-systolic volumes, LVEF, left atrium volume, GLS and LGE were significantly associated with long-term outcome. Multivariable analysis revealed that GLS and LGE were independently associated with long-term outcome (p<0.05, both). In additional analyses, we found independent associations between GLS and LV reverse remodelling after the optimal medical therapy, and between LGE and life-threatening arrhythmias (p<0.05, both). CONCLUSION: Combining GLS and LGE could be useful for risk stratification and prognostic assessment in patients with DCM. CI - Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/. FAU - Chimura, Misato AU - Chimura M AD - Himeji Cardiovascular Center, Himeji, Japan. FAU - Onishi, Tetsuari AU - Onishi T AD - Himeji Cardiovascular Center, Himeji, Japan. FAU - Tsukishiro, Yasue AU - Tsukishiro Y AD - Himeji Cardiovascular Center, Himeji, Japan. FAU - Sawada, Takahiro AU - Sawada T AD - Himeji Cardiovascular Center, Himeji, Japan. FAU - Kiuchi, Kunihiko AU - Kiuchi K AD - Himeji Cardiovascular Center, Himeji, Japan. FAU - Shimane, Akira AU - Shimane A AD - Himeji Cardiovascular Center, Himeji, Japan. FAU - Okajima, Katsunori AU - Okajima K AD - Himeji Cardiovascular Center, Himeji, Japan. FAU - Yamada, Shinichiro AU - Yamada S AD - Himeji Cardiovascular Center, Himeji, Japan. FAU - Taniguchi, Yasuyo AU - Taniguchi Y AD - Himeji Cardiovascular Center, Himeji, Japan. FAU - Yasaka, Yoshinori AU - Yasaka Y AD - Himeji Cardiovascular Center, Himeji, Japan. FAU - Kawai, Hiroya AU - Kawai H AD - Himeji Cardiovascular Center, Himeji, Japan. LA - eng PT - Journal Article DEP - 20161031 PL - England TA - Heart JT - Heart (British Cardiac Society) JID - 9602087 RN - 0 (Contrast Media) RN - K2I13DR72L (Gadolinium DTPA) SB - IM MH - Aged MH - Biomechanical Phenomena MH - Cardiomyopathy, Dilated/*diagnostic imaging/mortality/physiopathology/therapy MH - Chi-Square Distribution MH - Contrast Media/*administration & dosage MH - Disease-Free Survival MH - *Echocardiography, Doppler, Color MH - Female MH - Gadolinium DTPA/*administration & dosage MH - Heart Failure/mortality/physiopathology/therapy MH - Heart-Assist Devices MH - Humans MH - Kaplan-Meier Estimate MH - Longitudinal Studies MH - *Magnetic Resonance Imaging MH - Male MH - Middle Aged MH - Multivariate Analysis MH - *Myocardial Contraction MH - Observer Variation MH - Patient Readmission MH - Predictive Value of Tests MH - Proportional Hazards Models MH - Reproducibility of Results MH - Retrospective Studies MH - Risk Assessment MH - Risk Factors MH - Stress, Mechanical MH - Stroke Volume MH - *Ventricular Function, Left MH - Ventricular Remodeling EDAT- 2016/11/02 06:00 MHDA- 2017/07/25 06:00 CRDT- 2016/11/02 06:00 PHST- 2016/04/03 00:00 [received] PHST- 2016/10/04 00:00 [revised] PHST- 2016/10/05 00:00 [accepted] PHST- 2016/11/02 06:00 [pubmed] PHST- 2017/07/25 06:00 [medline] PHST- 2016/11/02 06:00 [entrez] AID - heartjnl-2016-309746 [pii] AID - 10.1136/heartjnl-2016-309746 [doi] PST - ppublish SO - Heart. 2017 May;103(9):679-686. doi: 10.1136/heartjnl-2016-309746. Epub 2016 Oct 31.